The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
Hospital chiefs asked by NHS regulator to fill vacancies only where "essential" as they face an unprecedented financial challenge.
The footballer and father-of-two said he is 'filled with pride' at being asked to take on the role.
A state of emergency has been declared as emergency crews struggle to overcome raging wildfires that have been burning for six days.